(Q48283906)

10 February 2018

title

Focused ultrasound-induced blood-brain barrier disruption enhances the delivery of cytarabine to the rat brain. (English)

1 reference

10 February 2018

0 references

1 reference

1 reference

Han-Qing Zeng

1

1 reference

10 February 2018

Lin Lü

2

1 reference

10 February 2018

Feng Wang

3

1 reference

10 February 2018

Yun Luo

4

1 reference

10 February 2018

Shi-Feng Lou

5

1 reference

10 February 2018

publication date

1 December 2012

1 reference

10 February 2018

published in

Journal of Chemotherapy

1 reference

10 February 2018

volume

24

1 reference

10 February 2018

issue

6

1 reference

10 February 2018

page(s)

358-363

1 reference

10 February 2018

Pharmacogenomics of cytarabine in childhood leukemia.

cites work

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000043

Controversies in the management of central nervous system leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000043

History of the treatment of childhood ALL: a paradigm for cancer cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000043

Chronic health conditions in adult survivors of childhood cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000043

Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000043

The role of chemotherapy and targeted agents in patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000043

Systemic chemotherapy for treatment of advanced small bowel adenocarcinoma with prognostic factor analysis: retrospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000043

Strategies for increasing drug delivery to the brain: focus on brain lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000043

Drug delivery to brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000043

Ultrasound-induced blood-brain barrier opening

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000043

Targeted gene delivery to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000043

Concurrent blood-brain barrier opening and local drug delivery using drug-carrying microbubbles and focused ultrasound for brain glioma treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000043

Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000043

Experimental study on targeted methotrexate delivery to the rabbit brain via magnetic resonance imaging-guided focused ultrasound.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000043

Future of convection-enhanced delivery in the treatment of brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000043

Convection enhanced drug delivery of novel therapeutic agents to malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000043

Targeted drug delivery across the blood-brain barrier using ultrasound technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000043

The threshold for brain damage in rabbits induced by bursts of ultrasound in the presence of an ultrasound contrast agent (Optison®)

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000043

Inflammatory mediators and modulation of blood-brain barrier permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000043

Ultrasound enhances reporter gene expression after transfection of vascular cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000043

Microbubbles and ultrasound: from diagnosis to therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000043

Microbubbles improve the ablation efficiency of extracorporeal high intensity focused ultrasound against kidney tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000043

The role of caveolin-1 in blood-brain barrier disruption induced by focused ultrasound combined with microbubbles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000043

A quantitative pressure and microbubble-size dependence study of focused ultrasound-induced blood-brain barrier opening reversibility in vivo using MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000043

Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000043

Enhanced therapeutic agent delivery through magnetic resonance imaging-monitored focused ultrasound blood-brain barrier disruption for brain tumor treatment: an overview of the current preclinical status

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000043

Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000043

Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000043

Translocator protein (TSPO) ligand-Ara-C (cytarabine) conjugates as a strategy to deliver antineoplastic drugs and to enhance drug clinical potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000043

Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000043

Neurologic complications of intrathecal liposomal cytarabine administered prophylactically to patients with non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000043

10.1179/1973947812Y.0000000043

21 January 2018

Identifiers

DOI

1 reference

10 February 2018

release_3n5hvfmnurbe7c6wvl6qrtpqym

Fatcat ID

0 references

1 reference

10 February 2018